Abstract
SAT-208 Sex hormone binding globulin as an effective predictor of treatment response toTERN-501, a potent, highly selective thyroid hormone receptor β agonist: post-hoc analyses from a 12-week phase 2a trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have